Borderline resectable pancreatic cancer

Explore this paper's citation graph

Summary

Patients whose tumors show radiographic stability or regression that are often accompanied by an improvement in serum tumor markers are candidates for pancreaticoduodenectomy and a prospective multicenter clinical trial with well-defined eligibility criteria may help decide the best overall treatment strategy for these patients.

Type
article
Published
2005-10-01
Cited by
47
References
51
Access
Open access

Keywords

Medicine, Microbiology, Internal medicine, Biology

References

Cited by

Related papers

No related papers recorded.